share_log

Caldwell Announces Passing of Board Chairman Elias Vamvakas

Caldwell Announces Passing of Board Chairman Elias Vamvakas

Caldwell宣佈董事會主席Elias Vamvakas去世
Accesswire ·  07/12 04:30

TORONTO, ON / ACCESSWIRE / July 11, 2024 / Talent acquisition firm The Caldwell Partners International Inc. (TSX:CWL)(OTCQX:CWLPF) today announced with regret that Board Chairman Elias Vamvakas has passed away after a courageous battle with cancer.

2024年7月11日,人才招聘公司The Caldwell Partners International Inc.(TSX:CWL)(OTCQX:CWLPF)宣佈董事會主席Elias Vamvakas在勇敢與癌症搏鬥後去世,令人痛心。

"It is with a heavy heart that we announce Elias' passing," said John Wallace, chief executive officer. "Elias was a loyal leader of our Board, respected mentor to me and collaborative partner to our Board members. He offered wise guidance and support - especially through the global pandemic and ensuing downturn, adding tremendous value to our company, our strategy and our people. He was a great colleague and an even better friend, and I feel an immense sense of gratitude to him for his insight, his perspective, his leadership, and his guidance the past five years here at Caldwell. On behalf of our Board of Directors and the entire Caldwell team, we extend our deepest sympathies to Elias' family."

首席執行官John Wallace表示:“我們懷着沉重的心情宣佈Elias去世。Elias是我們董事會的忠誠領導者,對我來說是一位值得尊敬的導師,對我們董事會成員是一位富有合作精神的夥伴。他提供了明智的指導和支持,特別是在全球大流行病和隨後的經濟下滑期間,爲我們的公司、我們的策略和我們的人員增加了巨大的價值。他是一位傑出的同事,更是一位更好的朋友,我對他爲Caldwell在過去五年中提供的洞察力、觀點、領導和指導感到無限感激。我們的董事會和整個Caldwell團隊謹向Elias的家人致以最深切的慰問。”

Mr. Vamvakas joined the Board in July of 2019 to fill the vacancy left by G. Edmund King's retirement. He was also the Chairman, CEO and founder of Greybrook Capital, a private equity firm focused on real estate and healthcare. Mr. Vamvakas was also chairman of Greenbrook-TMS NeuroHealth centers, (GTMS), the leading provider of TMS therapy in North America. He was also chairman of TearLab Corporation (TEAR), an ophthalmic device company developing and commercializing novel, lab-on-a-chip technologies that enable eye care practitioners to test for highly sensitive and specific biomarkers in tears at the point-of-care. Prior to Greybrook Capital, Mr. Vamvakas co-founded TLCVision (TLCV,TLC) where he served as Chairman and CEO.

Vamvakas先生於2019年7月加入董事會填補了由G. Edmund King退休所留下的空缺。他還是Greybrook Capital的董事長兼首席執行官和創始人,該公司專注於房地產和醫療保健的私人股權投資公司。Vamvakas先生還是Greenbrook-TMS NeuroHealth中心的主席(GTMS),這是北美領先的TMS療法提供商。他還是TearLab公司(TEAR)的主席,該公司開發和商業化了新穎的芯片實驗室技術,使眼科醫生能夠在診療現場測試高度敏感和特異性的淚液生物標誌物。在Greybrook Capital之前,Vamvakas先生共同創辦了TLCVision(TLCV,TLC),並擔任董事長和首席執行官。

Mr. Vamvakas is survived by his wife, Nancy Vamvakas; their three children, Olivia, Megan, and Michael; his father, Antonios Vamvakas; and his mother-in-law, Susan Fenwick.

Vamvakas先生的妻子Nancy Vamvakas和他們的三個孩子Olivia、Megan和Michael、他的父親Antonios Vamvakas以及他的岳母Susan Fenwick倖存下來。

About Caldwell Partners

關於Caldwell Partners

Caldwell Partners is a technology-powered talent acquisition firm specializing in recruitment at all levels. Through two distinct brands - Caldwell and IQTalent - the firm leverages the latest innovations in AI to offer an integrated spectrum of services delivered by teams with deep knowledge in their respective areas. Services include candidate research and sourcing through to full recruitment at the professional, executive and board levels, as well as a suite of talent strategy and assessment tools that can help clients hire the right people, then manage and inspire them to achieve maximum business results.

Caldwell Partners是一家利用最新的人工智能技術進行人才招聘的科技公司。通過兩個不同的品牌——Caldwell和IQTalent——該公司利用其各自領域的深厚知識,提供由候選人調研和採購到在專業、執行和董事層面的全面招聘服務,以及一套人才戰略和評估工具,幫助客戶僱用合適的人才,然後管理和激勵他們以實現最大的業務成果。

Caldwell Partners' common shares are listed on The Toronto Stock Exchange (TSX: CWL) and trade on the OTCQX Market (OTCQX: CWLPF). Please visit our website at for further information.

Caldwell Partners的普通股在多倫多證券交易所上市(TSX:CWL)並在OTCQX市場交易(OTCQX:CWLPF)。請訪問我們的網站 以獲取更多信息。

For further information, please contact:

如需更多信息,請聯繫:

Investors:
Chris Beck, President, and Chief Financial Officer
cbeck@caldwell.com
+1 (617) 934-1843

投資者:
Chris Beck,總裁兼首席財務官。
cbeck@caldwell.com
+1 (617) 934-1843

Media:
Caroline Lomot, Director of Marketing
clomot@caldwell.com
+1 (516) 830-3535

媒體:
市場營銷總監卡羅琳·洛莫特
clomot@caldwell.com
+1 (516) 830-3535

SOURCE: Caldwell Partners International, Inc.

SOURCE: Caldwell Partners International, Inc.


譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論